InvestorsHub Logo

imho

04/23/21 1:41 PM

#308021 RE: Steady_T #308011

One thing that happens if BIIB gets their drug approved is that it sets cost reference for AD treatment that is going to be quite high. That will give Anvex increased pricing power in the marketplace.

Probably the biggest positive thing for Anavex going forward. If, Anavex drug works as we hope and assume.

IMHO

tredenwater2

04/23/21 5:17 PM

#308034 RE: Steady_T #308011

All good Steady T unless it gives Biogunk a leg up on hostile actions towards acquiring us. They ARE familiar with our MOA as they were allowed to study our drug and they have all kinds of threatening patent issues with their MS portfolio. Does Dr. Missling and the BOD have a plan in place sufficient enough to thwart this event? Desparate times sometimes call for desperate measures by competitors.